Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implications.

Xu R, Zhao J, Liu M, Qiao Y, Ning X, Sun S

Open source

DOI
10.3389/fimmu.2026.1939528
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1939528,
  title = {Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implications.},
  author = {Xu R and Zhao J and Liu M and Qiao Y and Ning X and Sun S},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1939528},
  url = {https://doi.org/10.3389/fimmu.2026.1939528}
}

RIS

TY  - JOUR
TI  - Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implications.
AU  - Xu R
AU  - Zhao J
AU  - Liu M
AU  - Qiao Y
AU  - Ning X
AU  - Sun S
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1939528
UR  - https://doi.org/10.3389/fimmu.2026.1939528
ER  - 

APA

R, X., J, Z., M, L., Y, Q., X, N., & S, S. (2026). Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implications.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1939528

Source records